Reset filters
  • 19 October 2009

Etravirine, darunavir/ritonavir and raltegravir very effective in highly treatment-experienced patients

Read the article
  • 30 October 2008

Once-daily darunavir/ritonavir may be an option for some treatment-experienced patients

Read the article
  • 21 January 2008

Etravirine (TMC125, Intelence) granted accelerated approval in US

Read the article
  • 7 December 2007

Triple-class failure emerges slowly in UK patients

Read the article
  • 5 December 2007

Start treatment when CD4 cell count is 350, say revised US guidelines

Read the article
  • 26 October 2007

Bevirimat 300mg oral solution dose does well in study

Read the article
  • 25 October 2007

Undetectable viral load is goal for all, together with earlier treatment, say new European treatment guidelines

Read the article
  • 15 October 2007

Raltegravir receives accelerated approval from the FDA

Read the article
  • 4 October 2007

Most patients on incompletely suppressive therapy maintain CD4 counts and stable viral loads

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.